NASDAQ
ACADIA Pharmaceuticals Inc. (ACAD) has a free cash flow growth of 154.55% as of Friday, May 29, 2026. This represents a 386.79% increase compared to its 12-month average of -53.89%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.